Table: Fuji Pharmaceutical -Q1 group results

Fuji Pharma

06/02/2025 07:00

Feb 6 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Dec 31, 2024        Dec 31, 2023     Sep 30, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             13.00               10.75            53.36    
                 (+21.0 pct)         (+7.5 pct)       (+15.7 pct) 
  Operating          1.25           loss 140 mln          4.85    
                                                      (+25.0 pct) 
  Recurring          1.38            loss 96 mln          4.68    
                                                      (+5.3 pct)  
  Net              991 mln               2.74             3.38    
                 (-63.8 pct)        (+145.8 pct)      (-45.0 pct) 
  EPS             40.75 yen          112.73 yen       139.07 yen  
  Ann Div                             42.50 yen        45.50 yen  
  -Q2 div                             20.00 yen        20.00 yen  
  -Q4 div                             22.50 yen        25.50 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T